Inflammation-suppressing cornea-in-a-syringe with anti-viral GF19 peptide promotes regeneration in HSV-1 infected rabbit corneas.

"data availability the datasets generated during the current study are available in the figshare repository ( https://figshare com/s/e112efc30dfa0b17e954 ). data availability the datasets generated during the current study are available in the figshare"

"Competing interests M.Z.R. and M.G. have submitted a US provisional patent application on a related injectable MPC-based polymer formulation. The remaining authors declare no competing interests."

"We thank Meagan J. Latorre for her technical assistance. ERANET EuroNanoMed III supported this work through the Fonds de Recherche du Québec – Santé (FRQS; File #278653) and the Research Council of Lithuania (S-EURONANOMED-19-1/LSS-600000-2063). We also acknowledge support from the “Instituto de Salud Carlos III” (grant # ICI19/00006) to M.G.-A. Y.J.-G. acknowledges funding from Consejería de Salud y Familias, Junta de Andalucía, co-funded by Fondo Social Europeo de Andalucía 2014–2020. We are grateful to Fernando López-López and José Carlos Caceres-Salido Biobank Unit from Central Units of Support for Research (UCAIB) at the IMIBIC (Córdoba, Spain) for providing technical assistance. M.G. was also supported by NSERC Canada (RGPIN-2017-05410), CIHR (PJT 155924), Canada Research Chair Tier 1 in Biomaterials and Stem Cells in Ophthalmology (File #950232398), and a Caroline Durand Foundation Research Chair in Cellular Therapy in the Eye. M.M. thanks the University of Ottawa Heart Institute, the Strategic Research Endowed Funds for a Strategic Research Postdoctoral Fellowship, and the CIHR Fellowship MFE-186357. M.A.K. and N.C.T. are supported by PhD scholarships from the Maisonneuve-Rosemont Hospital Research Center, while M.Z.R. has a FRQS PhD scholarship."